Studies suggested Sigmar1 as a potential biomarker for lung cancer diagnosis and therapeutic targets as Sigmar1 levels were elevated in lung cancer in animal models as well as in tumor cell lines (Mach et al., 2013; van Waarde et al., 2015). This evidence concerns the gene SIGMAR1 and neoplasm.